Increasing of Msi2 expression levels in advanced stages of CML in comparison with chronic phase of CML patients predicate the increase of unusual activities of the Msi2-Numb signaling pathway; this expanded expression also has been reported in AML. Here, MSI2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.